Endocarditis Prevention S3.8-1. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:e521 643. S3.8-2. Verheugt CL, Uiterwaal CSPM, van der Velde ET, et al. Turning 18 with congenital heart disease: prediction of infective endocarditis based on a large population. Eur Heart J. 2011;32:1926 34. S3.8-3. Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, di- agnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J. 2009;30:2369 413. S3.8-4. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116:1736 54. S3.8-5. Allen U. Infective endocarditis: updated guidelines. Paediatr Child Health. 2010;15:205 12. 3.9. Concomitant Syndromes S3.9-1. van Engelen K, Topf A, Keavney BD, et al. 22q11.2 Deletion syn- drome is under-recognised in adult patients with tetralogy of Fallot and pulmonary atresia. Heart. 2010;96:621 4. S3.9-2. Fung WLA, Chow EWC, Webb GD, et al. Extracardiac features predicting 22q11.2 deletion syndrome in adult congenital heart di- sease. Int J Cardiol. 2008;131:51 8. S3.9-3. Hartman RJ, Rasmussen SA, Botto LD, et al. The contribution of chromosomal abnormalities to congenital heart defects: a popula- tion-based study. Pediatr Cardiol. 2011;32:1147 57. S3.9-4. Lin AE, Basson CT, Goldmuntz E, et al. 